arrow
C

Christina Cho

hackensack university medical center
H指数:25
被引数:2,733

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Outcomes of people living with acute lymphoblastic leukemia who received inotuzumab ozogamicin before a stem cell transplant: a plain language summary

接受伊诺妥珠单抗治疗并在干细胞移植前的急性淋巴细胞白血病患者结局:简易语言摘要

2025-12-070
OAAI
Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 study

基于模型的抗胸腺细胞球蛋白剂量在体外CD34+选择的同种异基因造血细胞移植中的应用:一项单中心、单臂、II期研究

2025-12-010
PRE
Outcomes of terminal complement blockade in adults with high-risk transplant-associated thrombotic microangiopathy: a comparative analysis

高危移植相关血栓性微血管病成人中终末补体阻滞的结局:一项比较分析

2025-11-280
PRE
Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell Transplant

异基因造血细胞移植后高价抗感染药物的医疗险障碍

2025-07-090
PRE
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse posttransplant

骨髓和血液显示出不同的免疫重建模式,并与移植后的复发存在关联。

2025-06-140
OAAI
Five-Year Real-World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B-Cell Precursor Acute Lymphoblastic Leukemia

在B-细胞前体急性淋巴细胞白血病中,伊诺妥珠单抗在造血干细胞移植前的五年真实世界安全性

2025-02-240
OAAI
Health-Related Values Discussions with Patients Undergoing Allogeneic and Autologous Stem Cell Transplant: Feasibility and Acceptability of an Early Primary Palliative Care Intervention
2025-02-010
PRE
Role of Endoscopic Techniques in the Diagnosis of Complications of Allogeneic Hematopoietic Stem Cell Transplantation: A Review of the Literature
2024-07-250
OAAI
A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia
2024-03-135
OAAI
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation
2023-09-131
OAAI
Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia
2023-09-091
PRE
Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia
2023-07-2613
OAAI
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
2023-05-1526
OAAI
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
2022-10-3115
OAAI
Racial disparities in access to alternative donor allografts persist in the era of donors for all
2022-10-1817
OAAI
Evaluation of Melphalan Exposure in Lymphoma Patients Undergoing BEAM and Autologous Hematopoietic Cell Transplantation

淋巴瘤患者接受BEAM和自体造血细胞移植的马法兰暴露评估

2022-08-010
OAAI
MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT

MAIT和Vδ2非常规T细胞由多种肠道微生物组支持,并与同种异体HCT后患者的良好预后相关

2022-05-2525
OA
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT
2022-03-0321
OAAI